{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:10:27Z","timestamp":1761581427729},"reference-count":25,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,9]]},"DOI":"10.18632\/oncotarget.9449","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T20:59:32Z","timestamp":1464037172000},"page":"52442-52449","source":"Crossref","is-referenced-by-count":6,"title":["Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Monika","family":"Joshi","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Medical Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monali","family":"Vasekar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Medical Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Grivas","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Emamekhoo","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"Miller","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Stephens","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siraj M.","family":"Ali","sequence":"additional","affiliation":[{"name":"Foundation Medicine, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pathology, Albany Medical College, Albany, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Medical Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Warrick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Drabick","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Medical Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon L.","family":"Holder","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Medical Oncology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Kaag","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Urology, Penn State Hershey Cancer Institute, Hershey, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumanta Kumar","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Abnet","year":"2011","journal-title":"JAMA"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014; 511:543\u2013550.","DOI":"10.1038\/nature13385"},{"key":"3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2012.08.024","article-title":"Genomic landscape of non-small cell lung cancer in smokers and never-smokers","volume":"150","author":"McDonald","year":"2012","journal-title":"Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.bjc.6603040","article-title":"Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking","volume":"94","author":"Yasumoto","year":"2006","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"The Cancer Genome Atlas Research N","year":"2014","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/1538-7445.AM2015-2969","article-title":"Abstract 2969: Progress in The Cancer Genome Atlas bladder cancer project","volume":"75","author":"Bajorin","year":"2015","journal-title":"Cancer Res"},{"key":"7","article-title":"Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations","author":"Stephens","year":"2015","journal-title":"Cancer"},{"key":"8","first-page":"4528","article-title":"Molecular characterization of bladder cancer in smokers versus non-smokers","volume":"33","author":"Drabick","year":"2015","journal-title":"ASCO Meeting Abstracts"},{"key":"9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/1078-0432.CCR-13-1992","article-title":"A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma","volume":"20","author":"Nahas","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Brennan","year":"2013","journal-title":"Nat Biotechnol"},{"key":"11","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine, Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study","volume":"18","author":"Wersall","year":"2000","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/annonc\/mdr156","article-title":"Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma","volume":"23","author":"Sonpavde","year":"2012","journal-title":"Ann Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Hegde","year":"2014","journal-title":"Nature"},{"key":"14","first-page":"4502","article-title":"Pembrolizumab (MK-3475) for advanced urothelial cancer: Updated results and biomarker analysis from KEYNOTE-012","volume":"33","author":"O'Donnell","year":"2015","journal-title":"ASCO Meeting Abstracts"},{"key":"15","unstructured":"Rosenberg, Hoffman-Censits, Powles, van der Heijden, Balar, Necchi, Dawson, O'Donnell, Balmanoukian, Loriot, Srinivas, Retz, Grivas, et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. The Lancet."},{"key":"16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Moreira","year":"2015","journal-title":"Science (New York, NY)"},{"key":"17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Weide","year":"2015","journal-title":"Science (New York, NY)"},{"key":"18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.1226344","article-title":"Genome sequencing identifies a basis for everolimus sensitivity","volume":"338","author":"Peng","year":"2012","journal-title":"Science (New York, NY)"},{"key":"19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.eururo.2015.01.015","article-title":"Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation","volume":"67","author":"Pal","year":"2015","journal-title":"Eur Urol"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Sequist, Cassier, Varga, Tabernero, Schellens, Delord, LoRusso, Camidge, Medina, Schuler, Campone, Tian, Wong, et al. Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors. Presented at the Annual Meeting of the American Association of Cancer Research. April 8, 2014. (Abstr CT 326) 20.","DOI":"10.1158\/1538-7445.AM2014-CT326"},{"key":"21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/432082","article-title":"Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations","volume":"77","author":"Cormier-Daire","year":"2005","journal-title":"Am J Hum Genet"},{"key":"22","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2014-04-570929","article-title":"NUP98\/NSD1 and FLT3\/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report","volume":"124","author":"Meshinchi","year":"2014","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1073\/pnas.0912493107","article-title":"Regulation of NF-kappaB by NSD1\/FBXL11-dependent reversible lysine methylation of p65","volume":"107","author":"Stark","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-2727-2_9","article-title":"Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-beta) Isoform mRNAs for the Treatment of Solid Tumors","volume":"1317","author":"Janicot","year":"2015","journal-title":"Methods Mol Bio"},{"key":"25","unstructured":"van Osch, Jochems, van Schooten, Bryan, Zeegers. Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis. J of Urol."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T02:09:17Z","timestamp":1656554957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":25,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2016,8,9]]}},"alternative-id":["9449","27213592"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9449","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}